MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor
ines to patients new medical options forphysicians and rewarding careers to employees. Dedicated to advancing scienceand medicine to help people live better lives the company is focused oninfection oncology respiratory disease and inflammation cardiovascular/gastrointestinal disease and neuroscience. Headquartered in GaithersburgMaryland MedImmune has approximately 3000 employees
Date:12/4/2008
ines to patients, new medical options for
physicians and rewarding careers to employees. Dedicated to advancing science
and medicine to help people live better lives, the company is focused on
infection, oncology, respiratory disease and inflammation, cardiovascular/
gastrointestinal disease and neuroscience. Headquartered in Gaithersburg,
Maryland, MedImmune has approximately 3,000 employees worldwide and is the
wholly owned biologics business for AstraZeneca PLC (LSE: AZN.L, NYSE:
AZN).
For more information, visit MedImmune's website at
http://www.medimmune.com.
'/>"/>SOURCE MedImmune Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 Related biology technology :1.
MedImmune Announces Zook as President2.
MedImmune Presents Data Highlighting its Progressive Inflammatory Disease Portfolio at the 72nd Annual Meeting of the American College of Rheumatology3.
MedImmune Licenses Reverse Genetics Technology to Hungarys Omninvest for Use in Influenza Vaccine Development and Production4.
MedImmune Expands R&D Capacity with New Research Facility in Cambridge, U.K.5.
MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease6.
Pinnacle Biologics Announces Stock Purchase Agreement With MedImmune7.
MedImmunes Brian Rosen Honored by Montgomery County Chamber at 49th Annual Awards Dinner8.
Depth of MedImmunes Respiratory Disease Research Program Highlighted at Annual Meeting of the American Thoracic Society9.
MedImmune Fortifies Strategic Scientific Portfolio Management and International Leadership With New Executive Appointments10.
MedImmune Presents Data Highlighting its Progressive Oncology Portfolio at Annual Meeting of the American Association For Cancer Research11.
Seneca Valley High School Student Receives Science Award From MedImmune